Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +50.81%
#3 DOVU DOVU +50.51%
#4 Cross Cross +49.17%
#5 Black Phoenix Black Phoenix +34.33%
#6 Velvet Velvet +32.01%
#7 OVERTAKE OVERTAKE +22.01%
#8 Cap Cap +17.55%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.87%
#10 Movement Movement +13.76%
Coin of the day
Glidr Glidr
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Agentix Corp. Agentix Corp.

Agentix Corp.

AGTX
Pozycja w akcjach #38792
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Cena akcji
$0.02
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$801.34K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-18.70%
Kraj
US
Handel Agentix Corp. (AGTX)

Kategoria

Healthcare
Historia ceny akcji dla Agentix Corp. (AGTX)
Najwyższa cena zamknięcia: $0.02 dnia 2026-08-01

Najniższa cena zamknięcia: $13.07 dnia 2015-08-01
Historia cen akcji firmy Agentix Corp. od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -6.56%
2025 -78.30%
2024 515.58%
2023 -72.91%
2022 -82.45%
2021 61.22%
2020 -98.30%
2019 128.57%
2018 -65.57%
2017 13.66%
2016 21.09%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $506.92 29.88%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $843.33 29.26%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE